Avanos Medical (NYSE:AVNS) Reaches New 1-Year Low at $31.27

Share on StockTwits

Avanos Medical Inc (NYSE:AVNS) hit a new 52-week low on Thursday . The company traded as low as $31.27 and last traded at $31.27, with a volume of 3767 shares changing hands. The stock had previously closed at $32.35.

AVNS has been the subject of a number of research analyst reports. Morgan Stanley lowered their price target on Avanos Medical from $36.00 to $32.00 and set an “underweight” rating for the company in a report on Tuesday, December 17th. Zacks Investment Research upgraded Avanos Medical from a “sell” rating to a “hold” rating and set a $46.00 price target for the company in a report on Wednesday, October 30th. ValuEngine downgraded Avanos Medical from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Stifel Nicolaus downgraded Avanos Medical from a “buy” rating to a “hold” rating and lowered their price target for the company from $45.00 to $35.00 in a report on Wednesday, November 6th. Finally, Raymond James downgraded Avanos Medical from an “outperform” rating to a “market perform” rating in a report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $45.20.

The firm has a market cap of $1.55 billion, a price-to-earnings ratio of -34.86 and a beta of 1.47. The company has a current ratio of 2.51, a quick ratio of 1.84 and a debt-to-equity ratio of 0.25. The stock has a 50-day moving average of $33.07 and a 200-day moving average of $36.50.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings data on Tuesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.02). Avanos Medical had a negative net margin of 6.20% and a positive return on equity of 3.92%. The company had revenue of $171.40 million for the quarter, compared to analyst estimates of $179.98 million. During the same quarter in the prior year, the firm earned $0.37 EPS. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year. As a group, research analysts expect that Avanos Medical Inc will post 1.04 earnings per share for the current fiscal year.

A number of large investors have recently added to or reduced their stakes in the stock. Diversified Trust Co boosted its position in Avanos Medical by 36.7% during the 4th quarter. Diversified Trust Co now owns 15,355 shares of the company’s stock valued at $517,000 after purchasing an additional 4,125 shares during the period. California State Teachers Retirement System boosted its position in Avanos Medical by 1.2% during the 3rd quarter. California State Teachers Retirement System now owns 73,715 shares of the company’s stock worth $2,761,000 after acquiring an additional 881 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Avanos Medical by 12.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 64,666 shares of the company’s stock worth $2,423,000 after acquiring an additional 7,213 shares during the period. AMG National Trust Bank boosted its position in Avanos Medical by 4.8% during the 3rd quarter. AMG National Trust Bank now owns 18,018 shares of the company’s stock worth $675,000 after acquiring an additional 822 shares during the period. Finally, Paradice Investment Management LLC boosted its position in Avanos Medical by 12.9% during the 3rd quarter. Paradice Investment Management LLC now owns 2,248,108 shares of the company’s stock worth $84,214,000 after acquiring an additional 256,525 shares during the period. Institutional investors and hedge funds own 93.08% of the company’s stock.

About Avanos Medical (NYSE:AVNS)

Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.

Read More: What is the definition of arbitrage?

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Essex Investment Management Co. LLC Takes Position in Broadcom Inc
Essex Investment Management Co. LLC Takes Position in Broadcom Inc
Schneider National Inc  Shares Sold by Essex Investment Management Co. LLC
Schneider National Inc Shares Sold by Essex Investment Management Co. LLC
Essex Investment Management Co. LLC Decreases Stock Holdings in Brunswick Co.
Essex Investment Management Co. LLC Decreases Stock Holdings in Brunswick Co.
Essex Investment Management Co. LLC Purchases New Holdings in Savara Inc
Essex Investment Management Co. LLC Purchases New Holdings in Savara Inc
Essex Investment Management Co. LLC Has $706,000 Stock Holdings in Twitter Inc
Essex Investment Management Co. LLC Has $706,000 Stock Holdings in Twitter Inc
Essex Investment Management Co. LLC Acquires New Shares in Colfax Corp
Essex Investment Management Co. LLC Acquires New Shares in Colfax Corp


© 2006-2020 Ticker Report